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Abstract 
Chronic Traumatic Encephalopathy (CTE) is a traumatic brain injury based disease that is garnering a lot of 
attention in the United States. The purpose of this paper is to conduct an extensive review of the information 
available about the condition. Recently there has been a limited amount of published information and treatment 
opportunities are rare since the only way of diagnosing has come post mortem. Various literary reviews and 
experiments were analyzed for appropriate information regarding CTE’s pathology and treatments and only peer 
reviewed published works were allowed in this paper. This resulted in promising information about the disease and 
the future treatments for the condition were viewed and will be used throughout this article.  
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Until recent development of advanced imaging 
technology very little was known about brain 
injuries. The brain is relatively hidden inside of a 
skull and there is limited viewing options 
without expensive imaging techniques (13). 
With these limitations, understanding of how 
impact to the head affected the brain was 
severely hindered, and only showed symptoms 
could be used to diagnose (7). Traumatic brain 
injuries (TBI) were considered any significant 
jolt or blow to the head that results in altered 
brain function or feeling (2). Many of the 
complications of severe traumatic brain injuries 
are well documented and established but the 
focus of this review is to highlight the mild 
traumatic brain injury (mTBI) known as the 
concussion and its correlation to CTE (10). A 
mild traumatic injury is a blow or jolt to the 
brain caused by a non-penetrating stimulus. 
Concussions are mild traumatic injuries that 
may have varying levels of severity, going from 
momentary dizziness to a brief loss of 
consciousness. Rarely are the immediate effects 
of the concussion long lasting so a mTBI was 
seen as harmless until recently (7). The 
correlation of concussions in collision based 
activities was tied to the onset of the disease 
CTE (Chronic Traumatic Encephalopathy) and 
the medical communities’ attitude towards this 
injury changed (7).  
CTE has an increasing impact in the world of 
neuroscience. CTE is known as a progressive 
tauopathy neurodegenerative disease (7). 
Before examining the clinical aspect of the 
disease this paper will first review a brief history 
of the condition. The first observed cases of CTE 
were thought to have come in the early 1900’s 
with boxing (2). In 1928 the term “punch drunk” 
was coined to describe the unpredictable 
behavioral, motor and cognitive functions 
coming from years of repeated nonlethal blows 
to the head, 10 years later Dr. Millspaugh called 
it dementia pugilistica and shortly changed to 
psychopathic deterioration of pugilists (7). In 
1949 the name Chronic Traumatic 
Encephalopathy was used and was cemented by 
Dr. Critchley (17). Over the next 30 years the 
scope of potential victims of CTE broadened to 
include all contact sports and the military with 
an especially high prevalence in football (Shown 
in figure 1). All of these sports would include 
repeated sub lethal blows to the head, often 
resulting in concussions.  
  
Figure 1: CTE Timeline (7) 
 Chronic Traumatic Encephalopathy begins to 
present symptoms  8-10 years after 
experiencing repeated head injuries, these 
symptoms are highlighted by headaches, rapid 
mood swings, impulsivity, increased irritability, 
aggression, memory loss, varying levels of 
depression and in some cases gait 
abnormalities; the most severe symptoms are 
suicidal thoughts and actions (2). The most 
recognizable physical symptom of CTE is the 
atrophy of the following key brain regions: 
cerebral cortex, temporal lobes, thalamus, 
mammillary bodies and the brain stem, leading 
to an abnormally low brain weight which leads 
to the observed symptoms above (2). CTE 
shares many signs and symptoms with 
Alzheimer’s disease, ALS and Parkinson’s 
disease which is why for years there was limited 
ability to distinguish CTE from other 
neurodegenerative disorders (1). CTE is initiated 
from repetitive mild traumatic brain injuries. 
These injuries cause widespread disposition of 
neurofibrillary tangles composed of hyper 
phosphorylated tau proteins, instead of the 
regularly phosphorylated tau. There is also a 
concentration of neurotoxic peptides beta 
amyloid and TDP-43 and PNN destruction (9). 
There has even been a possible gene 
association with CTE (3). The APOE e4 allele is 
linked with increased susceptibility (3). 
Neurodegenerative disorders are clinically 
distinguishable by the source of the brains 
degeneration. Neurodegeneration is the single 
most devastating effect of CTE and brain 
degeneration is always fatal when untreated. 
When this occurs, it will result in death unless 
the patient succumbs to another cause of death 
before the level of degeneration becomes fatal 
(9).    
CTE Specific Pathologies  
TAU: The primary cause of neuronal 
degeneration in CTE comes at the hand of the 
neurofibrillary tangles caused by the Tau-
protein, a condition commonly seen in 
Alzheimer’s disease and other frontotemporal 
dementias (1). Neurofibrillary tangles are 
consisted of aggregated straight or paired 
helical filaments, twisted ribbons and other 
forms of overly phosphorylated forms of the 
microtubule associated protein (MAP) known as 
tau (16). These lesions are the diagnostic 
hallmark of the condition, which as of now is 
hard to find with the currently available forms 
of imaging (16). It is increasingly evident that 
tau-mediated neurodegeneration is the result 
of a toxic gain of function mutation acquired by 
the tau that come from over phosphorylation of 
tau in the disease state (16). It is known that tau 
is key in the organization and stabilization of 
microtubules used in the central nervous 
system, which is very important in the 
structural organization of the brain (6). It is 
believed that tau may also have additional roles 
in its interaction with other structures and 
enzymes such as the actin in the cytoskeleton 
and tyrosine kinases (6). The build-up of p-tau 
causes changes in these structures but exactly 
how this change is caused is not quite 
understood (1). One of the likely scenarios is 
that once tau is phosphorylated, it enters an 
extremely active state where it interacts with 
the surrounding cellular structures that it 
normally would not influence (5). These 
reactions cause proteins in the brain to fold 
improperly, which triggers apoptosis (6). This 
error is considered a post translational 
modification because in the early stages of tau 
pathology there isn’t a change in the genetic 
properties; there is just an over 
phosphorylation of a protein triggered by 
structural damage (6). Other post translational 
modifications of tau include glycation, 
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ubiquitination, sumoylation and nitration (1). 
These are believed to occur at different stages 
of tau pathology and could be possibly be a way 
to establish how long CTE has been present in 
the patient.  
The ability for tau to modulate microtubule 
properties contributes to key structural and key 
regulatory cellular functions (9). Microtubules 
play major roles in maintaining neuronal 
morphology, the process that extend over long 
distances make the neuron the most 
asymmetrical of the cells so this morphology is 
important (16). Microtubules are also key in the 
transport machinery of neurons which allows 
the signaling molecules to move into or out of a 
cell. Under normal cell condition tau is in a 
constant equilibrium on and off the 
microtubules, being activated and deactivated 
when necessary (25). This equilibrium is 
controlled by the phosphorylation state of tau 
by kinases (1). In the case of a repetitive 
traumatic brain injuries the protein tau 
becomes phosphorylated at an increasingly high 
rate. The buildup of phosphorylated tau 
proteins leads to axonal transport defects, 
synapse loss and neuroinflammation (25). 
Studies of this protein have shown that the 
disengagement of tau from microtubules via 
phosphorylation is a critical step in the tau 
mediated neurodegeneration (1). There is a 
threshold of free phosphorylated tau that must 
be reached before it becomes toxic to the brain, 
and with traumatic brain injuries the amount of 
p-Tau increases. When the p-Tau level becomes 
toxic neurons begin to die and the Tau deposits 
spread (16).  
 Other neurotoxic peptides and PNN: 
Another symptom of repeated blows to the 
head is the disruption of the Perineuronal Net 
(PNN) (14).  PNN’s represent the highly 
organized components of the brains 
extracellular matrix (5). These nets surround 
cell bodies, dendrites and axons of particular 
classes of neurons forming lattice like 
structures. The roles of PNN’s are not 
completely understood yet, but they do play a 
beneficial role by stabilizing the extracellular 
matrix by protecting them from harmful agents 
(14). These barriers against chemical agents 
form a physical gate between the neural tissue 
and ECM. They create a barrier that limits 
neuronal plasticity and counteracts 
regeneration of neuronal circuits (6).  
The extracellular matrix in the central nervous 
system contains a highly organized mixture of 
proteoglycans, tenascin, fibronectin and a 
scaffolding substance called hyaluronan (6). 
These materials are dispersed all around the 
CNS but only particular neurons are enveloped 
completely by these PNN’s. The main 
component of the PNN is the proteoglycan. The 
specific proteoglycan varies depending on what 
type of cell the PNN is protecting (6). It is 
believed that the disruption of these PNN’s 
helps allow the hyper phosphorylated tau 
protein to build up in the brain when there is 
damage to the brain. The repellant properties 
of the PNN is compromised when there is 
damage and molecules that may naturally exist 
in the extracellular space are allowed contact 
with neurons and may be toxic (14). Along with 
the direct toxic effects of the tau protein, the 
damage to the PNN also releases the Amyloid 
beta peptide. This peptide is a natural occurring 
peptide in the body but when it is free in the 
extracellular matrix it initiates an immune 
response because the peptides are recognized 
as foreign, causing massive inflammation (15). 
The charge of the beta amyloid causes them to 
move towards neurons because that is their 
natural place as part of the PNN forming what is 
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called a senile plaque (similar to senile 
associated brain images) (14). This throws off 
the ionic balance and conductivity of the 
neurons, ultimately disrupting brain function. 
The immune response against these peptides 
near the neurons results in self damage in an 
attempt to remove the toxic peptides. When 
the plasticity limiting properties of PNN’s are 
very important to the way the brain 
communicates with the rest of the body and 
other areas of the brain (14). The brain 
primarily has 3 types of non-specialty neurons; 
those being inhibitory, excitatory and 
interneurons. The buildup up of the tau protein 
and beta amyloid peptide demonstrate a prion 
like toxic effect on PNN of the GABAergic 
neuron which is an interneuron (12). PNN show 
a very limited ability to regenerate on their 
own, leading to possible movement of neurons 
if repeated blows to the brain are received. 
Interneurons connect different areas of the 
brain, which is necessary for parallel processing 
used on a daily basis in human life. 
Overstimulation or under stimulation from a 
rearranged interneuron caused by traumatic 
brain injuries could be devastating to the 
normal processing ability of the brain (2).  
One preexisting condition that has been 
correlated with the onset of CTE is genetic (27).  
The gene apolipoprotein correlated to tau 
transcription has two versions, (apopE3) and E4 
(apopE4) (27).  ApopE4 when combined with 
traumatic brain injury resulted in a high risk of 
tau protein based neurodegenerative disorders 
were 2-4 times more likely than those with the 
E3 gene. This research was conducted in mice 
models, and it is believed the human brain 
follows the same physiological properties (28). 
In a study with TBI blasts conducted on mice 
those with the gene ApopE3 had levels of PIP2 
phosphate elevated which lead to a reduction in 
the PIP2 degrading enzyme synj1. In the mice 
with the ApopE4 gene the blast induced TBI the 
PIP2 phosphate levels did not change so there 
was no down regulation in synj1 (3). Soon after 
it was discovered that the amount of p-Tau in 
the E4 type dramatically outgained the amount 
in the E3 genotype. PIP2 is a signaling lipid that 
is involved with ion channel homeostasis, 
exocytosis and endocytosis. It also plays a role 
in cytoskeletal configuration and cell signaling. 
The enzyme SYNJ1 is responsible for the 
degradation of PIP2 (3).  
The experiment used to find these results were 
done by inducing a blast that would cause a 
non-penetrating TBI (4). The blast measured 
was blowing up a stick of TNT at a distance of 6 
meters from the subject. In the study, it was 
observed that in the CTE susceptible ApoE4 
genotyped subjects reduces PIP2 levels in 
mouse and in human brains but that reduction 
doesn’t happen early in the life of the mouse 
(4). Through the first 3 months of the life of the 
mouse the PIP2 levels post blast, remained 
constant between the two genotypes. This lead 
to the hypothesis that continued exposure to 
blasts causing TBI alters something in the ApoE4 
gene that is not in ApoE3(4). Interestingly 
enough, when the mRNA post blast was 
compared to the mRNA pre blast in each of the 
genotypes there was no observed change which 
lead to the new hypothesis that the true change 
in the gene expression came from a post 
transcriptional or post translational alteration. 
The steps of DNA to protein is a highly 
regulated process, The DNA (gene) under goes 
selection via a transcription factor, then 
undergoes transcription to create mRNA and 
then the mRNA is translated into a protein. In 
this experiment there is no alteration prior to 
transcription meaning that the DNA itself is not 
altered but there is an epigenetic change (28). 
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The conclusion gathered from these 
observations is that when the SYNJ1 enzyme is 
down regulated after a TBI in the ApoE3 
genome subjects, there is no dysregulation of 
PIP2 levels meaning no free phosphates capable 
of binding to tau proteins (4). The ApoE4 mice 
do not down regulate SYNJ1 causing an 
abundance of phosphates in the cell. This  
research concluded with observation that either 
gene provided subjects that tested positive for 
hyper phosphorylated tau but the ApoE4 
genotype provided a much higher rate of p-Tau, 
an indicator of CTE (3).  
 
Below is an image of a brain that tested positive for the pathologies explained. The clear neurodegeneration can 
be seen in the brain (10).   
  
Figure 2: Comparative Imaging of 2 Brains (10) 
Cerebral Cortex:  
The largest portion of the human brain is the 
cerebral cortex, and it plays a large role in 
memory, attention, perception, cognition, 
awareness, thought, language and 
consciousness. The reason it is called the 
cerebral cortex (thinking region) is because 
essentially all activities that are involved with 
our consciousness are coordinated here. It is 
located at the most anterior placement of the 
brain right behind your skull, effectively 
encasing the whole brain acting as the 
outermost “layer” for an idea of the location 
(10). The outer zone of the cerebral cortex is 
made up of neural tissue called gray matter. 
This is where the neuronal cell bodies are. The 
cerebral cortex is typically folded in order to 
increase surface area, allowing more space for 
more neurons in the limited space of the 
cranium (20). The different areas of the cerebral 
cortex are directly correlated with different 
functions which is why the initial side-effects of 
a TBI can vary because depending on where the 
bruising occurs there will be area specific 
symptoms (24). Initially after a TBI the swelling 
caused in the aftermath of tissue damage 
causes pressure to build pushing the cerebral 
cortex against the skull and interfering with all 
of the functions previously stated (20). This is 
why a swollen brain can result in difficulty in all 
conscious activity, but many of the 
subconscious activities remain functional 
(breathing, heart rate) (19). When the 
neurodegeneration from p-tau accumulation 
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begins, the cerebral cortex is usually the first 
place the damage is seen (17).  
 
Temporal Lobe:  
Interestingly enough, in many of the TBI cases 
an area of the cerebral cortex that initially 
suffers the most damage is the temporal lobe 
(8). The temporal lobe is responsible for 
establishing new memories, processing 
language and object recognition, which are 
three things a patient who suffers from CTE 
struggle with (17). There are primarily two 
different factors in this area specific damage 
from TBI. One of the hypothesis for this is the 
natural human reflex. Naturally when a person 
see’s a dangerous stimulus coming directly at 
them they turn their head away. This is seen 
constantly in collision sports or near explosions 
in an attempt to protect the eyes (10). When 
something potentially dangerous is coming at 
you, you close your eyes and turn away. With 
the temporal lobe being located on the sides of 
the brain right behind where the ears connect 
to the head, they a prone to direct impact and 
can sustain a significant amount of bruising 
(13). The structure of the brain usually makes it 
so there is an elastic type collision inside the 
cranium which causes the side opposite of the 
impact to absorb much of the physical damage 
from the brain movement towards that side of 
the skull (20).  
A second type of mTBI that has been correlated 
with concussions that damage the temporal 
lobe specifically are blast induced TBI (bTBI) (4). 
Between 10-20% of soldiers returning from 
Operation Iraqi Freedom have suffered from at 
least one of these injuries. The over 
pressurization due to the shockwave from a 
blast is the culprit for this type of damage. This 
type of blast in recent warfare has been the 
number one cause of mortality for American 
troops (4). Blast waves specifically have an 
effect on the organs with fluid filled membranes 
(e.g. lungs, bowels, brain, etc.). The brain also 
fits into that category because of the fluid filled 
ventricles, and all of the vasculature dispersed 
throughout the brain (8). The temporal lobe 
specifically is where the hearing and vestibular 
senses stimuli are relayed to understand the 
environment (17). These senses respond to a 
pressure gradient. When the shockwave of a 
blast is induced there is an extreme increase in 
pressure that feels like an extreme increase in 
gravity. This outward pressure increase in 
pressure causes such intense pressure increases 
in the brain which then leads to the initial 
damage to the brain (4).  Secondary damage 
comes from the hearing and vestibular fluid 
sacs being stimulated so intensely that they are 
over stimulating the brain, leading to the brain 
increasing the threshold response which 
ultimately would lead to the desensitization 
towards normal stimulus. A result of this over 
correction would be deafness and difficulty with 
balancing. Both are common symptoms of 
patients that have experienced blast 
shockwaves (4). Since damage to the temporal 
lobe is often seen with concussions caused by 
TBI this area is usually the first to result in a 
build-up of p-tau and the first area of CTE 
mediated neurodegeneration (1).  
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Figure 3. regions of the brain (29) 
 
Limbic System 
Thalamus/Hypothalamus: The thalamic region 
is extremely important in the human brain (21). 
It is given the task of receiving and relaying all 
sensory signals to the correct portion of the 
brain and also regulates consciousness, sleep, 
alertness and emotions (21). TBI’s that cause a 
change to the environment of the thalamus 
would lead to a disruption in any of the 
previously mentioned functions (21). 
Concussions in particular) rarely cause direct 
physical damage to the thalamus but the ones 
that do result in the loss of consciousness which 
can be permanent resulting in a coma. 
Secondary effects from inflammation in the 
non- thalamic regions in the brain lead to 
increased pressure on the thalamus causing 
impaired function. The primary side effects 
from inflammation to the thalamus are delayed 
reactions and processing of information (21). 
The thalamus also integrates the limbic system 
with the cerebral cortex which allows a person 
to be aware of their emotions (21). At advanced 
stages of CTE the p-Tau spreads toward the 
thalamus and is especially toxic, resulting in 
unpredictable emotions and difficulty sleeping 
and waking caused by damage to efferent 
neurons to the cerebral cortex (9). Damage to 
the thalamus has been proven difficult to 
correct because its location is in the middle of 
the brain. Currently only medications have been 
used in an attempt to correct the altered 
neuronal functions (5), anti-inflammatory 
medications reduce inflammation but the 
physical damage to the tissue of the brain is 
usually permanent, due to the inability for the 
brain to heal itself fully (25).    
Mammillary Bodies:  The mammillary bodies 
are a small region of the brain located between 
the brain stem and the cerebrum (19). This two-
lobed structure has been associate with long 
term memory and in other animals a sense of 
direction also originates here. When the brain is 
initially swollen after a TBI there can be a 
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suppression of long term memory retrieval and 
in the advanced stages of CTE there is 
permanent memory loss (10).  
 
 
Figure 4. Image of the inner regions of the brain (29). 
Brain Stem:  
The brain stem contains the centers for all of 
the autonomic processes such as breathing, 
cardiac and smooth muscle contractions and 
the digestive tract (19). Non-penetrating 
traumatic brain injuries that cause concussions 
typically do not have enough force to cause 
physical damage to the brain stem. The brain 
stem becomes damaged when the spread of 
hyper phosphorylated tau begins. This 
interferes with the functioning of the neural 
cells in the brain stem and leads to death. If a 
brain stem is damaged there is usually a need 
for respirator and feeding tube because the 
autonomic functions are impaired (19).  
Incidence and Diagnosis   
The incidence of mTBI’s are hard to measure 
because so many go unreported, which is why 
an effort has been made to treat all head 
injuries as if they were a concussion (22). It is 
known that repeated traumatic injuries are the 
only known link to CTE the most effective way 
to stop the disease is to stop head injuries (7). 
Realistically this is impossible, which is why 
efforts to find a way to effectively diagnose the 
disease. If the preventative measures cease and 
repeated head injuries lead to a confirmed case 
of CTE then a swift and effective treatment plan 
must begin immediately (22). First an effective 
way to diagnose CTE must be developed, and as 
of November 2017 there may be a promising 
development here. Until last November every 
confirmed case of CTE has come post-mortem 
(18). There have been no FDA approved 
treatment plans for CTE but possible solutions 
are in development. Led by Dr. Ben Omalu a 
special PET scan that highlights the specific tau 
protein deposits unique to CTE pathology has 
been developed. Although there has been one 
case observed, the subject that was observed 
had a scan that was consistent with what post 
mortem CTE subjects had shown. After the 
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subject died the brain was dissected and CTE 
was confirmed (18).  
So far there have been no reported cases of CTE 
in a person that has not experienced a 
concussion or other non-penetrating traumatic 
brain injury. Humans constantly place 
themselves in situations where TBI is a risk (17). 
Whether that is from the sports entertainment 
world or the military, we have shown that we 
are prone to placing ourselves into these 
situations. Since there has been published 
correlation of traumatic brain injuries and 
neurodegenerative diseases the amount of 
participants in the collision sports has declined 
(7). Even though precautions for prevention 
have been made there has been an increase in 
the amount of concussions reported. This is 
likely because of the increased attention to 
head injuries has led to better recognition and 
reporting of these injuries. It is widely believed 
that the actual amount of concussions 
sustained has lowered but the amount reported 
has increased. In reality concussions can be 
caused by many different things (9).  
Treatments  
When the preventative measures against 
concussions fail serious complications can 
occur, possibly leading to CTE. Many 
pharmacological agents can help against 
concussion symptoms, which may help prevent 
CTE. These include anti-inflammatory 
medications, cell cycle inhibitors, gene therapy 
and stem cell therapy.  
 
Anti-inflammatory and cell cycle 
inhibitors: Drugs of this nature have the 
ability to slow or even stop the progress of 
secondary symptoms following a mTBI. This is 
especially important in prevention of CTE 
because the secondary symptoms of TBI’s are 
what lead to CTE (5). An example of a 
medication that helps combat these secondary 
effects is minocycline. This drug is a tetracycline 
that displays neuroprotective and anti-
inflammatory functions. It inhibits pro-
inflammatory cytokines by suppression of IL-
1beta and IL-6 and also inhibits micro gliosis 
(the process of CNS response to pathogens) 
which leads to an effective prevention of 
apoptosis in neuronal tissue. In recent human 
trials it was shown that minocycline also 
reduced serum nerurofilaments (12). This is 
especially key in the case of CTE prevention 
because the culprit in causing CTE is the protein 
tau which comes from neurofilaments primarily 
in the cytoskeleton (1). 
Microglial proliferation after a mTBI is often 
observed and glial cells are known as the 
“quality controlmen” of the brain (23). 
Microglia operate by removing the debris from 
damaged regions and induce inflammation in 
order to supply more blood to the damaged 
area (12). The problem with inflammation in the 
brain is that there is an enclosed volume so this 
causes a pressure build-up which can alter brain 
function (23). A way to prevent glial 
proliferation and suppress this response would 
be by inhibiting the cell cycle in CNS tissue. In 
comparison to other areas of the body the brain 
does not have much tolerance for new cell 
growth after maturity (25). This is to protect the 
carefully mapped neuronal networks and a 
traumatic brain injury can cause already mature 
neurons to undergo cell cycle activation which 
leads to neuronal apoptosis. The drug 
flavopiridol effects the cyclic-dependent-kinase 
(CDK) inhibition which is the kinase signaling 
that controls mitotic steps in the cell (9). In 
human trials flavopiridol specifically blocked cell 
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cycle activation in neurons, astrocytes and 
microglia. Another inhibitor called roscovitine 
has demonstrated its ability to inhibit CDK 
causing a reduction in microglial activation, 
neuroinflammation and neurodegeneration 
weeks post injury. 
The examples above are options that have 
shown promising results in clinical trials but 
more possible anti-inflammatory treatments for 
the brain are still being developed. For example, 
erythropoietin is a glycoprotein native to the 
blood. It also has demonstrated 
neuroprotective properties by altering a variety 
of cellular and subcellular processes including 
suppression of apoptosis, inflammatory and 
antioxidative stress (9). This medication has not 
yet made it to human trials but has been very 
successful in the animal trials of TBI. A debate 
with many of these anti-inflammatory and cell 
cycle inhibiting drugs are what the possible 
long-term effects will be (9). For example, 
initially the drug class statins proved to be 
effective in treating the secondary symptoms of 
a TBI but case studies showed that long term 
side effects resulted in attention deficits, 
memory loss and decreased psychomotor 
speed. Statins are used in medicine for a variety 
of different reasons and now come with a FDA 
placed warning for possible cognitive side 
effects (9).  
 
Biopharmaceuticals:  The previously 
mentioned treatments are considered 
pharmacological interventions but promising 
advancements based on preclinical studies have 
focused on the use of biologics (stem cells, gene 
therapy).  
Neural stem cells and mesenchymal stem cells 
have shown the ability to restore and 
regenerate the damaged area of the brain in 
mouse models, therefore theoretically this 
would do the same in humans. The problem is 
that these stem cells have proven difficult to 
reach without damaging the brain (5). The 
number of available neuroblast (stem cells of 
the brain) also decreases with age placing a high 
demand for these neuroblast in age related 
cases of neurodegeneration in comparison to 
TBI. Another potential effective biological 
application would be controlling the translation 
process in gene expression. For example, the 
inhibitory pathway that leads to RhoA 
activation comes after a traumatic brain injury 
(9). This is used to suppress neuronal growth 
after damage has occurred in an attempt to 
limit possible spreading of a pathogen. If the 
activation of this pathway is blocked by 
dephosphorylating, then the is potential for 
neuron growth and regeneration. The inhibitor 
used would be called a ROCK inhibitor and 
could be an effective adjuvant to biologics for 
enhancing recovery from TBI (9).  
 
Noninvasive interventions:  
Two potential non-invasive therapies have 
possible benefits for TBI victims, those being 
physical exercise and transcranial magnetic 
stimulation (TMS) (30). Both have shown very 
effective results in pre-clinical studies. These 
have evoked neuroplasticity changes which 
ultimately lead to recovery of pre-injury 
functionality (30).  
Conclusion: 
CTE has a delayed pathology and this caused the 
disease to receive less attention than warranted, 
which delayed action to fund research towards 
effective treatments and a possible cure (24). 
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Although the discovery of CTE happened decades 
ago, the recent correlation with football has made 
it a lightning rod for conversation. With increased 
influence from the public, more funding for 
research backed by the National Football League. 
As of now there have been no proven cures for 
CTE, it must also be noted that having a 
concussion does not guarantee you will have this 
disease. Multiple concussions have been 
correlated with onset CTE but there are many 
people who have experienced multiple 
concussions with no evidence of the disease (24). 
The most effective treatment to CTE in the 
general population has been to limit or eliminate 
the risks of concussions. In all levels of football 
targeting a player’s head can lead to ejection on 
top of newer helmets that absorb kinetic energy 
better than previous years (13). Combat sports 
have altered their rules to protect heads better, 
the United States military has spent millions of 
dollars creating helmets to help with blast 
shockwaves (4). If preventative measures fail, 
then concussions must be treated with better 
urgency; many victims believe they are not a 
problem but slowly that mindset has begun to 
change. With the seemingly effective diagnosis 
protocol developed by Dr. Omalu if CTE is 
suspected no longer will health care providers 
wait until after death to observe neural tissue and 
effective attempts to stop pathogenesis will occur 
(18). In CTE confirmed live patient’s medications 
can be used in trials to determine what is effective 
and ideally cure the disease. Better dieting, and 
supplements have been shown in mouse models 
to prevent the onset of CTE and also directly help 
with concussion recovery and prevention in 
mouse observations. The fatty acid omega-3 has 
shown this ability (26). Long term trials are being 
conducted on whether or not this prevents CTE in 
humans.  
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Appendix A  
The citations in this review were done with APA format using the scientific 
numbering method. In the bibliography the sources are placed in alphabetical 
order, with the numbers showing the order of citation added to this paper.  
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Appendix B 
My external reviewers Dr. Michael J Boxenbaum and Dr. Scott Torness insisted that the content of this paper 
was sufficient. The only suggestions made to me were to keep a consistent tone/ flow throughout the paper 
and use citations even if I felt I knew the material without reading it in a journal. I have done my best to 
incorporate this advice.  
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